-
The 8th Yunnan Breast Cancer Summit Forum | Dr. Zhaoqing Fan: Overview of HR+/HER2- Breast Cancer Treatment Landscape and Prospects of Immunotherapy in Early-Stage Patients
On July 14, the “8th Yunnan Breast Cancer Summit Forum” was held in Kunming, coinciding with the 40th anniversary of the Yunnan Cancer Hospital. This event, organized by the Yunnan Anti-Cancer Association and the China Medical Education Association, and co-hosted by eight institutions including the Peking University Cancer Hospital Yunnan Branch, Yunnan Cancer Hospital, and…
-
Evaluation of the Efficacy and Safety of Entrectinib Targeted Therapy for ROS1 Fusion Detected in Peripheral Blood
The development of modern oncology has provided multiple breakthrough treatment options for lung cancer, making it one of the fastest-evolving solid tumors. To help clinicians comprehensively grasp the significant advancements in this field, “Oncology Frontier” collaborates with Dr. Hua Zhong and Dr. Baohui Han from the Department of Respiratory and Critical Care Medicine at Shanghai…
-
Professor Yutao Zhan: Monitoring and Prevention of NAFLD-Related Liver Cancer
In recent years, the burden of non-alcoholic fatty liver disease (NAFLD) and liver cancer has become increasingly heavy, with a growing incidence of NAFLD-related hepatocellular carcinoma (HCC). Recently, Professor Yutao Zhan from Beijing Tongren Hospital delivered a fascinating presentation titled “Advances in Research on NAFLD-Related Liver Cancer.” The presentation comprehensively analyzed the prevention and control…
-
BOC/BOA 2024 | Dr. Qiang Liu: China’s Breast Cancer Research at the Forefront of the World, ctDNA-Guided Precision Treatment Development Trend
From July 5-7, 2024, the “2024 Annual Progress in Clinical Oncology Conference (BOC) and Best of ASCO® 2024 China (BOC/BOA)” was grandly held in Guangzhou. In the field of breast cancer, this conference highlighted key advancements from the American Society of Clinical Oncology (ASCO) annual meeting, showcasing China’s research impact on the international stage. “Oncology…
-
Applying Integrated Medicine in Breast Cancer Prevention and Treatment | Dr. Jiong Wu, 2024 CACA Conference
On July 12-13, the 2024 CACA Integrated Breast Cancer Conference was held in Kunming, hosted by the Chinese Anti-Cancer Association (CACA) and the CACA Integrated Breast Cancer Committee, and organized by the China Academy of Integrated Medicine and Strategy Development, Yunnan Cancer Hospital, and ten professional committees. “Oncology Frontier” invited Dr. Jiong Wu, Chairman of…
-
Advancing Comprehensive Breast Cancer Care: Prevention, Screening, Diagnosis, Treatment, and Rehabilitation | Dr. Jin Zhang, 2024 CACA Conference
The “2024 CACA Integrated Breast Cancer Conference,” hosted by the Chinese Anti-Cancer Association and the Chinese Anti-Cancer Association’s Breast Cancer Committee, was held in Kunming, Yunnan, from July 12-13, 2024. The conference, under the theme “Cancer Prevention and Treatment: Winning Through Integration,” focused on new concepts, knowledge, and technologies in breast cancer diagnosis and treatment,…
-
Cardiac Safety Management in Antitumor Therapy: Current Challenges and Future Development of Cardio-Oncology | Dr. Fengqi Fang, 2024 CACA Conference
With the continuous advancement of cancer treatment technologies, the survival rate of cancer patients has significantly improved, but the issue of cardiac safety during antitumor therapy has increasingly become a clinical focus. In this context, cardio-oncology has emerged as an important interdisciplinary field. At the “2024 CACA Integrated Breast Cancer Conference,” during the breast cancer…
-
Dr. Songqing Ye: Analysis of 2024 ASCO Breast Cancer ADC Research Progress
At the 2024 ASCO Conference, the progress in breast cancer ADC (antibody-drug conjugate) research was remarkable. T-DXd demonstrated excellent efficacy in HER2-positive breast cancer, significantly extending patient survival and reinforcing the concept of using the best drugs first. In HR-positive and triple-negative breast cancer, Dato-DXd showed good safety and efficacy, laying the foundation for future…
Connecting Medical Expertise through Media